Position in EXEL
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$223,081
New position
Shares Held
4,100
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#568
of 751 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Facet Wealth, Inc. holds $459,524 across 2 Biotechnology names. EXEL ranks #2 (48.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
476 | $236,443 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
4,100 | $223,081 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,081 | 4,100 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||